首页 > 最新文献

Journal of Vascular Surgery最新文献

英文 中文
Editor’s Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair 编者选择- ENGAGE注册中心对血管内腹主动脉瘤修复的耐用支架系统的十年结果进行了研究
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-13 DOI: 10.1016/j.jvs.2025.12.162
H.J.M. Verhagen, J.A.W. Teijink, A.H. Power, M.M.P.J. Reijnen, L.H. Bouwman, F.E.G. Vermassen, V. Riambau, P. Erhart, S. Ling, P.W.M. Cuypers, I.M. Loftus, ENGAGE Investigators
{"title":"Editor’s Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair","authors":"H.J.M. Verhagen, J.A.W. Teijink, A.H. Power, M.M.P.J. Reijnen, L.H. Bouwman, F.E.G. Vermassen, V. Riambau, P. Erhart, S. Ling, P.W.M. Cuypers, I.M. Loftus, ENGAGE Investigators","doi":"10.1016/j.jvs.2025.12.162","DOIUrl":"10.1016/j.jvs.2025.12.162","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Page 965"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146172749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse childhood experiences, adult hardships, and disease severity in peripheral artery disease 外周动脉疾病的不良童年经历、成年困难和疾病严重程度。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-14 DOI: 10.1016/j.jvs.2025.11.011
Natalie V. Hmeluk BS , Martina Jelley MD, MSPH, FACP , Juell Homco PhD, MPH , Wato Nsa MD, PhD , Peter R. Nelson MD, MS, FACS , Julie Miller-Cribbs MSW, PhD , Arad Abadi MD , Kelly Kempe MD, MS, FACS
<div><h3>Background</h3><div>Childhood abuse, neglect, and household dysfunction, collectively known as adverse childhood experiences (ACEs), are strongly associated with the development of severe outcomes from chronic diseases, including ischemic heart attacks and stroke. ACEs also contribute to a higher risk of adult hardships, which increases the risk of health risk behaviors, chronic disease, and social problems. In this study, we describe the period prevalence of ACEs in a patient population with peripheral artery disease (PAD) and explore the relationship between childhood adversity, adult hardships, and PAD severity, such as the need for surgical procedures, among patients with PAD.</div></div><div><h3>Methods</h3><div>In this survey-based, cross-sectional study, individuals with PAD were recruited at an academic outpatient vascular surgery clinic (2022-2025). The survey included five questions about adult hardships—self-reported financial, food, medical, and housing insecurity in the past year—and 10 questions based on the original Centers for Disease Control and Prevention-Kaiser Permanente ACE study. We collected cardiovascular disease-related and amputation surgical procedure data from patient charts. PAD severity was determined by minor (eg, peripheral stent) or major (eg, amputation) surgical procedures and ankle-brachial index and toe-brachial index scores. The Wilcoxon rank-sum test and Fisher exact and χ<sup>2</sup> tests were used to assess differences in ACE or adult hardship scores as either continuous or categorical variables, respectively, in relation to cardiovascular disease-related surgical procedures.</div></div><div><h3>Results</h3><div>A total of 138 participants with PAD were included in the final analysis. Most respondents identified as male (55.8%, n = 77) and White (65.9%, n = 91). For childhood adversity, 37.0% (n = 51) reported experiencing no ACEs, 24.6% (n = 34) reported one ACE, 10.9% (n = 15) reported two ACEs, 10.1% (n = 14) reported three ACEs, and 17.4% (n = 24) reported at least four ACEs. The patient characteristics associated with a high number of ACEs included women, single individuals, Black individuals, and those living in poverty. The median ACE score was significantly higher for those who reported the following adult hardships compared with those who did not: not getting enough to eat (median, 3.0 vs 1.0; <em>P</em> < .001), being behind on bills (median, 2.0 vs 0.0; <em>P</em> < .001), and experiencing disconnected utilities (median, 3.0 vs 1.0; <em>P</em> = .001). No statistically significant association was noted between reporting ACEs and PAD severity or adult hardships and PAD severity.</div></div><div><h3>Conclusions</h3><div>Our findings suggest that a greater number of ACEs may indirectly contribute to an individual's risk for adult hardships in the PAD population, potentially placing these patients at higher risk of poor health outcomes. We did not find evidence to support a significa
童年虐待、忽视和家庭功能障碍,统称为不良童年经历(ace),与慢性疾病(包括缺血性心脏病发作和中风)的严重后果发展密切相关。不良经历还会增加成年后生活困难的风险,从而增加健康风险行为、慢性病和社会问题的风险。在这项研究中,我们描述了在PAD患者群体中ace的时期患病率,并探讨了PAD患者中童年逆境、成年困难和PAD严重程度(如需要手术治疗)之间的关系。方法:在这项基于调查的横断面研究中,在学术门诊血管外科诊所招募了PAD患者(2022-2025)。该调查包括5个关于成年人困难的问题——过去一年里自我报告的财务、食物、医疗和住房不安全状况,以及10个基于CDC-Kaiser Permanente ACE研究的问题。我们从患者图表中收集心血管疾病相关和截肢手术的数据。PAD的严重程度由轻微(如外周支架)或主要(如截肢)外科手术以及踝肱指数(ABI)和脚趾肱指数(TBI)评分来确定。使用Wilcoxon秩和检验和Fisher精确卡方检验分别评估与心血管疾病相关外科手术相关的ACE或成人困难评分作为连续变量或分类变量的差异。结果:共有138名PAD患者被纳入最终分析。大多数被调查者为男性(55.8%,n=77)和白人(65.9%,n=91)。对于童年逆境,37.0% (n=51)报告没有经历过ACE, 24.6% (n=34)报告一次ACE, 10.9% (n=15)报告两次ACE, 10.1% (n=14)报告三次ACE, 17.4% (n=24)报告至少四次ACE。与ace发生率高相关的患者特征包括女性、单身个体、黑人和贫困人群。与那些没有报告以下成年困难的人相比,报告以下成年困难的人的ACE得分中位数显着更高:吃不饱(中位数=3.0 vs. 1.0, p < 0.001),拖欠账单(中位数=2.0 vs. 0.0, p < 0.001),经历中断公用事业(中位数=3.0 vs. 1.0, p = 0.001)。报告ace与PAD严重程度或成人生活困难与PAD严重程度之间没有统计学意义的关联。结论:我们的研究结果表明,在PAD人群中,较高数量的ace可能间接增加了个人成年后的困难风险,可能使这些患者面临更高的不良健康结果风险。我们没有发现证据支持ace和pad严重程度之间的显著关系。其他可改变的危险因素值得持续分析,以改善PAD患者的管理。
{"title":"Adverse childhood experiences, adult hardships, and disease severity in peripheral artery disease","authors":"Natalie V. Hmeluk BS ,&nbsp;Martina Jelley MD, MSPH, FACP ,&nbsp;Juell Homco PhD, MPH ,&nbsp;Wato Nsa MD, PhD ,&nbsp;Peter R. Nelson MD, MS, FACS ,&nbsp;Julie Miller-Cribbs MSW, PhD ,&nbsp;Arad Abadi MD ,&nbsp;Kelly Kempe MD, MS, FACS","doi":"10.1016/j.jvs.2025.11.011","DOIUrl":"10.1016/j.jvs.2025.11.011","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Childhood abuse, neglect, and household dysfunction, collectively known as adverse childhood experiences (ACEs), are strongly associated with the development of severe outcomes from chronic diseases, including ischemic heart attacks and stroke. ACEs also contribute to a higher risk of adult hardships, which increases the risk of health risk behaviors, chronic disease, and social problems. In this study, we describe the period prevalence of ACEs in a patient population with peripheral artery disease (PAD) and explore the relationship between childhood adversity, adult hardships, and PAD severity, such as the need for surgical procedures, among patients with PAD.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;In this survey-based, cross-sectional study, individuals with PAD were recruited at an academic outpatient vascular surgery clinic (2022-2025). The survey included five questions about adult hardships—self-reported financial, food, medical, and housing insecurity in the past year—and 10 questions based on the original Centers for Disease Control and Prevention-Kaiser Permanente ACE study. We collected cardiovascular disease-related and amputation surgical procedure data from patient charts. PAD severity was determined by minor (eg, peripheral stent) or major (eg, amputation) surgical procedures and ankle-brachial index and toe-brachial index scores. The Wilcoxon rank-sum test and Fisher exact and χ&lt;sup&gt;2&lt;/sup&gt; tests were used to assess differences in ACE or adult hardship scores as either continuous or categorical variables, respectively, in relation to cardiovascular disease-related surgical procedures.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 138 participants with PAD were included in the final analysis. Most respondents identified as male (55.8%, n = 77) and White (65.9%, n = 91). For childhood adversity, 37.0% (n = 51) reported experiencing no ACEs, 24.6% (n = 34) reported one ACE, 10.9% (n = 15) reported two ACEs, 10.1% (n = 14) reported three ACEs, and 17.4% (n = 24) reported at least four ACEs. The patient characteristics associated with a high number of ACEs included women, single individuals, Black individuals, and those living in poverty. The median ACE score was significantly higher for those who reported the following adult hardships compared with those who did not: not getting enough to eat (median, 3.0 vs 1.0; &lt;em&gt;P&lt;/em&gt; &lt; .001), being behind on bills (median, 2.0 vs 0.0; &lt;em&gt;P&lt;/em&gt; &lt; .001), and experiencing disconnected utilities (median, 3.0 vs 1.0; &lt;em&gt;P&lt;/em&gt; = .001). No statistically significant association was noted between reporting ACEs and PAD severity or adult hardships and PAD severity.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Our findings suggest that a greater number of ACEs may indirectly contribute to an individual's risk for adult hardships in the PAD population, potentially placing these patients at higher risk of poor health outcomes. We did not find evidence to support a significa","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 848-858.e4"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk profiles and long-term mortality in premature and nonpremature peripheral artery disease from two prospective cohorts 来自两个前瞻性队列的过早和非过早PAD的风险概况和长期死亡率。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-07 DOI: 10.1016/j.jvs.2025.11.001
Xiaoqi Ye MD, PhD , Yan Li MD, PhD , Siyu Chen MD, PhD , Lihong Chen MD, PhD , Yebei Liang MD, PhD , Feiyan Shi MD , Xingwu Ran MD

Background

Peripheral artery disease (PAD), particularly premature PAD, remains understudied. It is still unclear whether premature PAD exhibits distinct risk profiles and survival outcomes compared with nonpremature PAD. We aimed to compare risk factors and long-term mortality between premature and nonpremature PAD using two large cohorts.

Methods

In this study, we analyzed data from the UK Biobank (N = 348,766) and the U.S. National Health and Nutrition Examination Survey (NHANES; N = 6539). Premature PAD was defined using a sex-specific age cutoff (men <55 years, women <65 years), with sensitivity analyses using a 50-year cutoff. Participants were classified into three groups: no PAD, premature PAD, and nonpremature PAD groups. Multinomial logistic regression assessed associations between risk factors and PAD subtypes. Cox proportional hazards models estimated associations of PAD subtypes with all-cause and cardiovascular mortality risks.

Results

Patients with premature PAD were predominantly female with fewer cardiometabolic comorbidities. Peripheral neuropathy was a strong risk factor specifically for premature PAD (UK Biobank: odds ratio [OR] = 3.96, 95% confidence interval [CI]: 2.73-5.73; NHANES: OR = 2.01, 95% CI: 1.28-3.17), whereas nonpremature PAD showed no significant association (UK Biobank: OR = 1.32, 95% CI: 0.66-2.65; NHANES: OR = 0.87, 95% CI: 0.65-1.16). Over a mean follow-up period of 13.2 (UK Biobank) and 14.9 (NHANES) years, unadjusted analyses showed the highest mortality in nonpremature PAD among the three groups. However, after full adjustment for potential confounders, the patterns of mortality shifted. Premature PAD had a higher all-cause mortality risk (UK Biobank: hazard ratio [HR] = 2.15, 95% CI: 1.93-2.39; NHANES: HR = 2.15, 95% CI: 1.41-3.29) than nonpremature PAD (UK Biobank: HR = 1.91, 95% CI: 1.75-2.09; NHANES: HR = 1.52, 95% CI: 1.28-1.80). Premature PAD also had a higher cardiovascular mortality risk (UK Biobank: HR = 3.10, 95% CI: 2.33-4.13; NHANES: HR = 4.33, 95% CI: 2.47-7.57) vs nonpremature PAD (UK Biobank: HR = 2.26, 95% CI: 1.76-2.88; NHANES: HR = 1.66, 95% CI: 1.34-2.07). This was further confirmed in a direct comparison among patients with PAD, which showed that premature PAD carried a significantly higher risk of cardiovascular mortality than nonpremature PAD.

Conclusions

Premature PAD exhibited distinct risk profiles and had higher adjusted long-term mortality than nonpremature PAD, particularly from cardiovascular causes. Future studies are needed to investigate the mechanisms underlying these differences.
背景:外周动脉疾病(PAD),尤其是早发性PAD,仍未得到充分研究。目前尚不清楚与非早发性PAD相比,早发性PAD是否表现出不同的风险特征和生存结果。我们的目的是通过两个大队列比较过早和非过早PAD的危险因素和长期死亡率。方法:在本研究中,我们分析了来自英国生物银行(N = 348,766)和美国国家健康与营养检查调查(NHANES; N = 6,539)的数据。研究结果:过早PAD患者以女性为主,心脏代谢合并症较少。周围神经病变(PN)是早发性PAD的重要危险因素(UK Biobank OR=3.96, 95% CI: 2.73-5.73; NHANES OR=2.01, 1.28-3.17),而非早发性PAD无显著相关性(UK Biobank OR=1.32, 0.66-2.65; NHANES OR=0.87, 0.65-1.16)。经过平均13.2年(UK Biobank)和14.9年(NHANES)的随访,未经调整的分析显示,三组中非早发性PAD的死亡率最高。然而,在对潜在的混杂因素进行全面调整后,死亡率的模式发生了变化。过早PAD的全因死亡风险(UK HR=2.15, 1.93-2.39; NHANES HR=2.15, 1.41-3.29)高于非过早PAD (UK HR=1.91, 1.75-2.09; NHANES HR=1.52, 1.28-1.80)。与非过早PAD (UK HR=2.26, 1.76-2.88; NHANES HR=1.66, 1.34-2.07)相比,过早PAD也有更高的心血管死亡风险(UK HR=3.10, 2.33-4.13; NHANES HR=4.33, 2.47-7.57)。在PAD患者之间的直接比较中进一步证实了这一点,该研究表明,过早PAD的心血管死亡风险明显高于非过早PAD。结论:与非早发性PAD相比,早发性PAD表现出明显的风险特征,调整后的长期死亡率更高,尤其是心血管原因。未来的研究需要调查这些差异背后的机制。
{"title":"Risk profiles and long-term mortality in premature and nonpremature peripheral artery disease from two prospective cohorts","authors":"Xiaoqi Ye MD, PhD ,&nbsp;Yan Li MD, PhD ,&nbsp;Siyu Chen MD, PhD ,&nbsp;Lihong Chen MD, PhD ,&nbsp;Yebei Liang MD, PhD ,&nbsp;Feiyan Shi MD ,&nbsp;Xingwu Ran MD","doi":"10.1016/j.jvs.2025.11.001","DOIUrl":"10.1016/j.jvs.2025.11.001","url":null,"abstract":"<div><h3>Background</h3><div>Peripheral artery disease (PAD), particularly premature PAD, remains understudied. It is still unclear whether premature PAD exhibits distinct risk profiles and survival outcomes compared with nonpremature PAD. We aimed to compare risk factors and long-term mortality between premature and nonpremature PAD using two large cohorts.</div></div><div><h3>Methods</h3><div>In this study, we analyzed data from the UK Biobank (N = 348,766) and the U.S. National Health and Nutrition Examination Survey (NHANES; N = 6539). Premature PAD was defined using a sex-specific age cutoff (men &lt;55 years, women &lt;65 years), with sensitivity analyses using a 50-year cutoff. Participants were classified into three groups: no PAD, premature PAD, and nonpremature PAD groups. Multinomial logistic regression assessed associations between risk factors and PAD subtypes. Cox proportional hazards models estimated associations of PAD subtypes with all-cause and cardiovascular mortality risks.</div></div><div><h3>Results</h3><div>Patients with premature PAD were predominantly female with fewer cardiometabolic comorbidities. Peripheral neuropathy was a strong risk factor specifically for premature PAD (UK Biobank: odds ratio [OR] = 3.96, 95% confidence interval [CI]: 2.73-5.73; NHANES: OR = 2.01, 95% CI: 1.28-3.17), whereas nonpremature PAD showed no significant association (UK Biobank: OR = 1.32, 95% CI: 0.66-2.65; NHANES: OR = 0.87, 95% CI: 0.65-1.16). Over a mean follow-up period of 13.2 (UK Biobank) and 14.9 (NHANES) years, unadjusted analyses showed the highest mortality in nonpremature PAD among the three groups. However, after full adjustment for potential confounders, the patterns of mortality shifted. Premature PAD had a higher all-cause mortality risk (UK Biobank: hazard ratio [HR] = 2.15, 95% CI: 1.93-2.39; NHANES: HR = 2.15, 95% CI: 1.41-3.29) than nonpremature PAD (UK Biobank: HR = 1.91, 95% CI: 1.75-2.09; NHANES: HR = 1.52, 95% CI: 1.28-1.80). Premature PAD also had a higher cardiovascular mortality risk (UK Biobank: HR = 3.10, 95% CI: 2.33-4.13; NHANES: HR = 4.33, 95% CI: 2.47-7.57) vs nonpremature PAD (UK Biobank: HR = 2.26, 95% CI: 1.76-2.88; NHANES: HR = 1.66, 95% CI: 1.34-2.07). This was further confirmed in a direct comparison among patients with PAD, which showed that premature PAD carried a significantly higher risk of cardiovascular mortality than nonpremature PAD.</div></div><div><h3>Conclusions</h3><div>Premature PAD exhibited distinct risk profiles and had higher adjusted long-term mortality than nonpremature PAD, particularly from cardiovascular causes. Future studies are needed to investigate the mechanisms underlying these differences.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 814-825.e10"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eight-year single- center experience with double-layer carotid stent 八年单中心双层颈动脉支架治疗经验。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-28 DOI: 10.1016/j.jvs.2025.11.027
Gianbattista Parlani MD , Giacomo Isernia MD, PhD , Lydia Romano MD , Francesco Pio Del Mastro MD , Piergiorgio Cao MD, FRCS , Massimo Lenti MD, PhD , Gioele Simonte MD, PhD

Objective

The aim of this study was to provide perioperative and mid-term evaluation, safety, and efficacy of CGuard (InspireMD) micromesh self-expanding stent with an embolic protection system during a carotid artery stenting (CAS) procedure.

Methods

All patients who underwent CAS with CGuard stent from January 2016 to June 2024 in a tertiary center were prospectively evaluated. The primary end points were technical success, combined risk of any stroke or death within 30 days (perioperative), and any ipsilateral stroke after the procedure. Secondary end points were stroke, death, transient ischemic attack, myocardial infarction (major adverse event), occurring within 30 days and the rate of stroke, death, and restenosis during the follow-up.

Results

A total of 218 consecutive patients underwent 226 CAS procedures with the CGuard stent during the study period. There were 142 male (63%) and mean age was 74.3 ± 8.0 years. Fifty-nine patients (26%) had a symptomatic stenosis. Technical success was 99.5%, because in 1 patient advancing the CGuard stent in a tight stenosis was impossible despite predilation. The mean procedural time was 33 minutes, the mean fluoroscopic time was 11 minutes, and the mean contrast media used was 41 mL. At 30 day, one patient had a transient ischemic attack (0.5%) and another patient experienced a minor stroke (0.5%). No patient died or developed myocardial infarction. The mean hospitalization duration after the procedure was 1.5 days. The 30-day rate of major adverse event was 0.5%. During a mean follow-up 35 months (range, 1-84 months), one patient had an asymptomatic stent occlusion and two patients experienced restenosis >70% successfully treated with a secondary stenting procedure in one case and stent explantation with Dacron patch closure in the other. The estimate of freedom from restenosis was 99.4% at 1 year, 97.5% at 3 years, and 97.5% at 5 years. Freedom from ipsilateral stroke was estimated 99.6% at 1 year, 98.7% at 3 years, and 98.7% at 5 years. The actuarial survival rate was 97.4% at 1 year, 92.4% at 3 years, and 78.7% at 5 years.

Conclusions

Preliminary data suggest that the CGuard stent with embolic protection system is an effective and safe device for the treatment of carotid artery stenosis with acceptably low perioperative and mid-term neurological event and durable patency rate. Larger, multicenter, randomized studies are advocated to confirm these findings.
目的:本研究的目的是在颈动脉支架置入(CAS)过程中对CGuard (InspireMD, Tel Aviv, Israel)微孔自膨胀支架(EPS)进行围手术期和中期评估、安全性和有效性。方法:2016年1月至2024年6月在三级中心接受颈动脉支架置入(CAS)的所有患者进行前瞻性评估。主要终点为技术成功、30天内卒中或死亡的综合风险(围手术期)以及术后同侧卒中。次要终点为30天内发生的卒中、死亡、短暂性脑缺血发作(TIA)、心肌梗死(主要不良事件或MAE)以及随访期间卒中、死亡和再狭窄的发生率。结果:在研究期间,共有218例连续患者接受了226例使用C Guard支架的CAS手术。男性142例(63%),平均年龄74.3(+ 8)岁。59例(26%)有症状性狭窄。技术上的成功率为99.5%,在一名患者中,尽管预扩张导致狭窄,但仍无法推进C保护支架。平均手术时间33分钟,平均荧光时间11分钟,平均使用造影剂41毫升。30天,1例患者发生短暂性脑缺血发作(0.5%),1例患者发生轻度脑卒中(0.5%)。无患者死亡或发生心肌梗死。术后平均住院时间为1.5天。30天MAE利率为0.5%。在平均随访35个月(1-84个月)期间,1例患者出现无症状支架闭塞,2例患者出现再狭窄,其中1例70%成功地接受了二次支架置入,另1例70%成功地接受了涤纶补片闭合支架置入。估计1年、3年和5年的再狭窄自由度分别为99.4%、97.5%和97.5%。估计1年时同侧卒中自由率为99.6%,3年时为98.7%,5年时为98.7%。精算生存率为1年97,4%,3年92,4%,5年77,7%。结论:初步数据表明,EPS CGuard支架是治疗颈动脉狭窄的有效和安全的装置,可接受的围手术期和中期神经事件低,持久的通畅率。我们提倡进行更大规模的多中心随机研究来证实这些发现。
{"title":"Eight-year single- center experience with double-layer carotid stent","authors":"Gianbattista Parlani MD ,&nbsp;Giacomo Isernia MD, PhD ,&nbsp;Lydia Romano MD ,&nbsp;Francesco Pio Del Mastro MD ,&nbsp;Piergiorgio Cao MD, FRCS ,&nbsp;Massimo Lenti MD, PhD ,&nbsp;Gioele Simonte MD, PhD","doi":"10.1016/j.jvs.2025.11.027","DOIUrl":"10.1016/j.jvs.2025.11.027","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to provide perioperative and mid-term evaluation, safety, and efficacy of CGuard (InspireMD) micromesh self-expanding stent with an embolic protection system during a carotid artery stenting (CAS) procedure.</div></div><div><h3>Methods</h3><div>All patients who underwent CAS with CGuard stent from January 2016 to June 2024 in a tertiary center were prospectively evaluated. The primary end points were technical success, combined risk of any stroke or death within 30 days (perioperative), and any ipsilateral stroke after the procedure. Secondary end points were stroke, death, transient ischemic attack, myocardial infarction (major adverse event), occurring within 30 days and the rate of stroke, death, and restenosis during the follow-up.</div></div><div><h3>Results</h3><div>A total of 218 consecutive patients underwent 226 CAS procedures with the CGuard stent during the study period. There were 142 male (63%) and mean age was 74.3 ± 8.0 years. Fifty-nine patients (26%) had a symptomatic stenosis. Technical success was 99.5%, because in 1 patient advancing the CGuard stent in a tight stenosis was impossible despite predilation. The mean procedural time was 33 minutes, the mean fluoroscopic time was 11 minutes, and the mean contrast media used was 41 mL. At 30 day, one patient had a transient ischemic attack (0.5%) and another patient experienced a minor stroke (0.5%). No patient died or developed myocardial infarction. The mean hospitalization duration after the procedure was 1.5 days. The 30-day rate of major adverse event was 0.5%. During a mean follow-up 35 months (range, 1-84 months), one patient had an asymptomatic stent occlusion and two patients experienced restenosis &gt;70% successfully treated with a secondary stenting procedure in one case and stent explantation with Dacron patch closure in the other. The estimate of freedom from restenosis was 99.4% at 1 year, 97.5% at 3 years, and 97.5% at 5 years. Freedom from ipsilateral stroke was estimated 99.6% at 1 year, 98.7% at 3 years, and 98.7% at 5 years. The actuarial survival rate was 97.4% at 1 year, 92.4% at 3 years, and 78.7% at 5 years.</div></div><div><h3>Conclusions</h3><div>Preliminary data suggest that the CGuard stent with embolic protection system is an effective and safe device for the treatment of carotid artery stenosis with acceptably low perioperative and mid-term neurological event and durable patency rate. Larger, multicenter, randomized studies are advocated to confirm these findings.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 767-774"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter regarding “Prediction of arteriovenous fistula maturation” 关于“预测动静脉瘘成熟”的信
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-13 DOI: 10.1016/j.jvs.2025.10.094
Ning Zhuo MD
{"title":"Letter regarding “Prediction of arteriovenous fistula maturation”","authors":"Ning Zhuo MD","doi":"10.1016/j.jvs.2025.10.094","DOIUrl":"10.1016/j.jvs.2025.10.094","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 968-969"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146169995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter regarding “Increased aortic-related mortality for clinically frail patients following F/BEVAR” 关于“F/BEVAR后临床虚弱患者主动脉相关死亡率增加”的信函
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-13 DOI: 10.1016/j.jvs.2025.10.068
Dongyang Li MMed , Xinyue Zhang MMed , Chenkai Xu MMed , Yanwei Du MD
{"title":"Letter regarding “Increased aortic-related mortality for clinically frail patients following F/BEVAR”","authors":"Dongyang Li MMed ,&nbsp;Xinyue Zhang MMed ,&nbsp;Chenkai Xu MMed ,&nbsp;Yanwei Du MD","doi":"10.1016/j.jvs.2025.10.068","DOIUrl":"10.1016/j.jvs.2025.10.068","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Page 967"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146169997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review and meta-analysis on endovascular repair of nonelective thoracoabdominal aortic aneurysms and aneurysms involving visceral arteries 非择期胸腹主动脉瘤和累及内脏动脉的动脉瘤血管内修复的系统回顾和荟萃分析。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-08-28 DOI: 10.1016/j.jvs.2025.08.030
Paolo Spath MD, PhD, FEBVS , Federica Campana MD , Nikolaos Tsilimparis MD, PhD, FEBVS , Enrico Gallitto MD, PhD, FEBVS , Stefania Caputo MD , Rodolfo Pini MD, PhD, FEBVS , Gianluca Faggioli MD, PhD , Mauro Gargiulo MD, PhD

Introduction

Thoracoabdominal aortic aneurysms (TAAAs) and juxta/pararenal abdominal aortic aneurysms, reported as complex aortic aneurysms (cAAAs), represent a technical and clinical challenge with endovascular repair embodying a preferred option for high-risk patients. However, in case of nonelective presentation, both technical and clinical management and outcomes remain limited in literature. The aim of this study is to report indications, treatments, and outcomes of nonelective endovascular repair of TAAAs and cAAAs.

Methods

This study is a systematic review and meta-analysis performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) and after PROSPERO registration. Primary end points were the indications, technical success, and procedure-related mortality. Secondary end points were spinal cord ischemia (SCI), grade 3 SCI, dialysis, and respiratory events. Meta-regression was performed for nonintact vs intact aneurysms. Subgroup analysis was performed in studies involving exclusively TAAA repair.

Results

Of 687 articles screened, we selected 18 articles involving 953 patients: TAAAs were 68% (51% Crawford I-III and 49% Crawford IV-V) and cAAAs were 32%. Indications for nonelective treatment were contained of free rupture, symptoms, and large aneurysm diameter. Branched endograft, physician-modified/in situ endograft, parallel graft, and fenestrated endograft were used in 54%, 30%, 14%, and 2%, respectively. Technical success was 94.4%. Overall procedural-related mortality was 16.8% (95% confidence interval: 0.13-0.22; nonintact: 24.5% vs intact: 11.8%; P < .001). Pooled rate for SCI and grade 3 SCI was 12.3% (nonintact: 21.9% vs intact: 8.9%; P = .007) and 5.2% (nonintact: 8.5% vs intact: 2.2%; P = .02), respectively. Pooled rate for permanent dialysis was 3.6% (nonintact: 6.1% vs intact: 1.7%; P = .08) and for respiratory events 14.1% (nonintact: 20.7% vs intact: 9.3%; P = .024). Subgroups analysis for TAAAs reported procedure-related mortality in 18.7% (nonintact: 24.8% vs intact: 12.6%; P = .08); SCI, grade 3 SCI, dialysis, and respiratory events occurred in 16.4% (nonintact: 21.9% vs intact: 9.7%; P = .06), 5.6% (nonintact:8.1% vs intact: 2.8%; P = .08), 5.4% (nonintact: 7.2% vs intact: 2.6%; P = .36), and 18.2% (nonintact: 23.1 vs intact: 10.5%; P = .10), respectively. No statistical differences in metaregression for nonintact vs intact TAAAs.

Conclusions

The indications for nonelective endovascular treatment of TAAA and cAAA are heterogeneous. Technical success is elevated while early mortality and spinal cord injuries were higher for ruptured aneurysm. Interestingly, TAAA outcomes seemed not to be influenced by rupture.
胸腹主动脉瘤(TAAA)和肾旁/旁腹主动脉瘤被报道为复杂的主动脉瘤(cAAA),是一项技术和临床挑战,血管内修复是高风险患者的首选选择。血管内修复是高风险患者的首选技术和临床挑战。然而,在非选择性表现的情况下,技术和临床管理和结果在文献中仍然有限。本研究的目的是报告非选择性血管内修复TAAA和cAAA的适应证、治疗方法和结果。方法:本研究根据系统评价和荟萃分析指南的首选报告项目(PRISMA)并在PROSPERO注册后进行系统评价和荟萃分析。主要终点是指征、技术成功和手术相关死亡率。次要终点是脊髓缺血(SCI)、3级SCI、透析和呼吸事件。对非完整动脉瘤和完整动脉瘤进行meta回归分析。对仅涉及TAAA修复的研究进行亚组分析。结果:在筛选的687篇文章中,我们选择了18篇文章,涉及953例患者:TAAA占68% (51% Crawford I-III, 49% Crawford IV-V), cAAA占32%。非选择性治疗的适应症是包含/自由破裂、症状、大直径动脉瘤。分支式、医师改良/原位式、平行式和开窗式分别占54%、30%、14%和2%。技术成功率为94.4%。总体手术相关死亡率为16.8%(95%可信区间0.13-0.22;非完整:24.5% VS完整:11.8%)结论:非选择性血管内治疗TAAA和cAAA的适应症具有异质性。技术上的成功提高了,而动脉瘤破裂的早期死亡率和脊髓损伤更高。有趣的是,TAAA的结果似乎不受破裂的影响。
{"title":"Systematic review and meta-analysis on endovascular repair of nonelective thoracoabdominal aortic aneurysms and aneurysms involving visceral arteries","authors":"Paolo Spath MD, PhD, FEBVS ,&nbsp;Federica Campana MD ,&nbsp;Nikolaos Tsilimparis MD, PhD, FEBVS ,&nbsp;Enrico Gallitto MD, PhD, FEBVS ,&nbsp;Stefania Caputo MD ,&nbsp;Rodolfo Pini MD, PhD, FEBVS ,&nbsp;Gianluca Faggioli MD, PhD ,&nbsp;Mauro Gargiulo MD, PhD","doi":"10.1016/j.jvs.2025.08.030","DOIUrl":"10.1016/j.jvs.2025.08.030","url":null,"abstract":"<div><h3>Introduction</h3><div>Thoracoabdominal aortic aneurysms (TAAAs) and juxta/pararenal abdominal aortic aneurysms, reported as complex aortic aneurysms (cAAAs), represent a technical and clinical challenge with endovascular repair embodying a preferred option for high-risk patients. However, in case of nonelective presentation, both technical and clinical management and outcomes remain limited in literature. The aim of this study is to report indications, treatments, and outcomes of nonelective endovascular repair of TAAAs and cAAAs.</div></div><div><h3>Methods</h3><div>This study is a systematic review and meta-analysis performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) and after PROSPERO registration. Primary end points were the indications, technical success, and procedure-related mortality. Secondary end points were spinal cord ischemia (SCI), grade 3 SCI, dialysis, and respiratory events. Meta-regression was performed for nonintact vs intact aneurysms. Subgroup analysis was performed in studies involving exclusively TAAA repair.</div></div><div><h3>Results</h3><div>Of 687 articles screened, we selected 18 articles involving 953 patients: TAAAs were 68% (51% Crawford I-III and 49% Crawford IV-V) and cAAAs were 32%. Indications for nonelective treatment were contained of free rupture, symptoms, and large aneurysm diameter. Branched endograft, physician-modified/in situ endograft, parallel graft, and fenestrated endograft were used in 54%, 30%, 14%, and 2%, respectively. Technical success was 94.4%. Overall procedural-related mortality was 16.8% (95% confidence interval: 0.13-0.22; nonintact: 24.5% vs intact: 11.8%; <em>P</em> &lt; .001). Pooled rate for SCI and grade 3 SCI was 12.3% (nonintact: 21.9% vs intact: 8.9%; <em>P</em> = .007) and 5.2% (nonintact: 8.5% vs intact: 2.2%; <em>P</em> = .02), respectively. Pooled rate for permanent dialysis was 3.6% (nonintact: 6.1% vs intact: 1.7%; <em>P</em> = .08) and for respiratory events 14.1% (nonintact: 20.7% vs intact: 9.3%; <em>P</em> = .024). Subgroups analysis for TAAAs reported procedure-related mortality in 18.7% (nonintact: 24.8% vs intact: 12.6%; <em>P</em> = .08); SCI, grade 3 SCI, dialysis, and respiratory events occurred in 16.4% (nonintact: 21.9% vs intact: 9.7%; <em>P</em> = .06), 5.6% (nonintact:8.1% vs intact: 2.8%; <em>P</em> = .08), 5.4% (nonintact: 7.2% vs intact: 2.6%; <em>P</em> = .36), and 18.2% (nonintact: 23.1 vs intact: 10.5%; <em>P</em> = .10), respectively. No statistical differences in metaregression for nonintact vs intact TAAAs.</div></div><div><h3>Conclusions</h3><div>The indications for nonelective endovascular treatment of TAAA and cAAA are heterogeneous. Technical success is elevated while early mortality and spinal cord injuries were higher for ruptured aneurysm. Interestingly, TAAA outcomes seemed not to be influenced by rupture.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 675-687.e3"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144959023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical aspects and midterm results of retrograde open mesenteric stenting for acute mesenteric ischemia 急性肠系膜缺血逆行开放肠系膜支架置入的技术方面和中期结果。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-14 DOI: 10.1016/j.jvs.2025.11.012
Nathanael Khayat MD , Adriane Mage MD , Iannis Ben Abdallah MD, MhD , Thierry Reix MD, PhD , Yves Castier MD, PhD , Joseph Touma MD, PhD , Arnaud Roussel MD, PhD , Jean Sénémaud MD, PhD

Background

Retrograde open mesenteric stenting (ROMS) may provide satisfactory initial results for the treatment of mesenteric ischemia. However, this procedure remains technically demanding and its complications may lead to significantly higher morbidity, mortality, and reinterventions rates in severely ill patients. This study aimed to report stent-related complications and midterm outcomes of ROMS for acute mesenteric ischemia (AMI).

Methods

Clinical data and outcomes of all consecutive patients treated with ROMS for AMI between February 2014 and December 2021 at three university hospitals were reviewed retrospectively. End points included technical success, in-hospital mortality, postoperative complications, stent-related complications, and reinterventions. Three-year overall survival, freedom from reintervention, primary patency, and assisted primary patency rates were analyzed using the Kaplan-Meier time-to-event method.

Results

Sixty-five patients presenting with AMI were included, of which 27 (40.5%) had a history of chronic mesenteric ischemia. All patients presented with mesenteric artery occlusive disease, involving the superior mesenteric artery (in situ thrombosis, n = 46; >70% stenosis, n =19). Overall technical success rate of the ROMS procedure in the cohort was 88%. The overall intestinal resection rate in the cohort was 35.4% (n = 23 patients). In-hospital mortality rate was 31.2%. Stent-related complications at 30 days were reported in 26.3% of patients, including ROMS occlusion (n = 7), residual superior mesenteric artery lesion (dissection/thrombus, n = 4), distal stent kinking (n = 2), and stent migration (n = 2). The mean follow-up duration was 24.9 months. The estimated 3-year overall survival rate for the cohort was 59.7% (95% confidence interval [CI], 46.7%-70.5%). Eight patients required additional stent-related reinterventions during follow-up, giving an estimate of freedom from stent-related reintervention at three years of 68.2% (95% CI, 50%-81%). The estimated three-year primary patency and assisted primary patency rates were 81.3% (95% CI, 65.4%-90.4%) and 87.6% (95% CI, 72.3%-94.7%), respectively.

Conclusions

ROMS provides acceptable technical success rate and midterm outcomes but is associated with high mortality, bowel resection, and specific stent-related complication rates. Such complications, resulting in frequent reinterventions and additional mortality, could be mitigated by implementing specific technical tips.
简介:逆行开放肠系膜支架(ROMS)治疗肠系膜缺血可提供满意的初步结果。然而,这种手术在技术上仍然要求很高,其并发症可能导致严重患者的发病率、死亡率和再干预率显著增加。本研究旨在报道ROMS治疗急性肠系膜缺血的支架相关并发症和中期预后。方法:回顾性分析2014年2月至2021年12月在三所大学附属医院连续接受ROMS治疗急性肠系膜缺血患者的临床资料和结局。终点包括技术成功、住院死亡率、术后并发症、支架相关并发症和再干预。使用Kaplan-Meier时间到事件法分析三年总生存率、无再干预、原发性通畅率和辅助原发性通畅率。结果:共纳入急性肠系膜缺血患者65例,其中有慢性肠系膜缺血史的患者27例(40.5%)。所有患者均表现为肠系膜动脉闭塞性疾病,累及肠系膜上动脉(SMA,原位血栓形成,n = 46, bb0 70%狭窄n =19)。队列中ROMS程序的总体技术成功率为88%。该队列的总体肠切除术率为35.4% (n = 23例)。住院死亡率为31.2%。26.3%的患者报告了30天支架相关并发症,包括ROMS闭塞(n = 7),残余SMA病变(剥离/血栓,n = 4),远端支架扭结(n = 2)和支架移位(n = 2)。平均随访时间为24.9个月。该队列的三年总生存率估计为59.7%(95%可信区间- ci - 46.7-70.5)。8名患者在随访期间需要额外的支架相关再干预,估计三年内支架相关再干预的自由度为68.2% (95% CI: 50-81)。估计三年原发性通畅率和辅助原发性通畅率分别为81.3% (95% CI: 65.4-90.4)和87.6% (95% CI: 72.3-94.7)。结论:ROMS提供了可接受的技术成功率和中期结果,但被认为具有较高的死亡率、肠切除术和特定支架相关并发症发生率。这种并发症导致频繁的再干预和更高的死亡率,可通过具体的技术提示加以缓解。
{"title":"Technical aspects and midterm results of retrograde open mesenteric stenting for acute mesenteric ischemia","authors":"Nathanael Khayat MD ,&nbsp;Adriane Mage MD ,&nbsp;Iannis Ben Abdallah MD, MhD ,&nbsp;Thierry Reix MD, PhD ,&nbsp;Yves Castier MD, PhD ,&nbsp;Joseph Touma MD, PhD ,&nbsp;Arnaud Roussel MD, PhD ,&nbsp;Jean Sénémaud MD, PhD","doi":"10.1016/j.jvs.2025.11.012","DOIUrl":"10.1016/j.jvs.2025.11.012","url":null,"abstract":"<div><h3>Background</h3><div>Retrograde open mesenteric stenting (ROMS) may provide satisfactory initial results for the treatment of mesenteric ischemia. However, this procedure remains technically demanding and its complications may lead to significantly higher morbidity, mortality, and reinterventions rates in severely ill patients. This study aimed to report stent-related complications and midterm outcomes of ROMS for acute mesenteric ischemia (AMI).</div></div><div><h3>Methods</h3><div>Clinical data and outcomes of all consecutive patients treated with ROMS for AMI between February 2014 and December 2021 at three university hospitals were reviewed retrospectively. End points included technical success, in-hospital mortality, postoperative complications, stent-related complications, and reinterventions. Three-year overall survival, freedom from reintervention, primary patency, and assisted primary patency rates were analyzed using the Kaplan-Meier time-to-event method.</div></div><div><h3>Results</h3><div>Sixty-five patients presenting with AMI were included, of which 27 (40.5%) had a history of chronic mesenteric ischemia. All patients presented with mesenteric artery occlusive disease, involving the superior mesenteric artery (in situ thrombosis, n = 46; &gt;70% stenosis, n =19). Overall technical success rate of the ROMS procedure in the cohort was 88%. The overall intestinal resection rate in the cohort was 35.4% (n = 23 patients). In-hospital mortality rate was 31.2%. Stent-related complications at 30 days were reported in 26.3% of patients, including ROMS occlusion (n = 7), residual superior mesenteric artery lesion (dissection/thrombus, n = 4), distal stent kinking (n = 2), and stent migration (n = 2). The mean follow-up duration was 24.9 months. The estimated 3-year overall survival rate for the cohort was 59.7% (95% confidence interval [CI], 46.7%-70.5%). Eight patients required additional stent-related reinterventions during follow-up, giving an estimate of freedom from stent-related reintervention at three years of 68.2% (95% CI, 50%-81%). The estimated three-year primary patency and assisted primary patency rates were 81.3% (95% CI, 65.4%-90.4%) and 87.6% (95% CI, 72.3%-94.7%), respectively.</div></div><div><h3>Conclusions</h3><div>ROMS provides acceptable technical success rate and midterm outcomes but is associated with high mortality, bowel resection, and specific stent-related complication rates. Such complications, resulting in frequent reinterventions and additional mortality, could be mitigated by implementing specific technical tips.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 729-737"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric aortic trauma: A review of the literature 儿童主动脉创伤:文献综述。
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-10-30 DOI: 10.1016/j.jvs.2025.10.036
Malachi Sheahan MD , Sarah Lauve MD , Amanda Tullos MD , John White MD , Regan Williams MD , Dawn Coleman MD , Claudie M. Sheahan MD

Background

The patterns of pediatric aortic injury have changed and the incidence of penetrating aortic trauma, secondary to ballistic injuries, is increasing. Patterns of treatment have also changed, with fewer open aortic repairs as more endovascular technologies evolve and are able to be applied to the pediatric population.

Methods

This is a review of the current available literature regarding pediatric aortic injury both penetrating and blunt in the abdominal and thoracic aorta.

Results

When comparing thoracic aortic injuries (TAIs) to abdominal aortic injuries (AAIs), TAI is associated with higher mortality rates. Overall, blunt injuries are more common than penetrating injuries, and there are higher mortality rates associated with penetrating mechanisms. Improvements in endovascular repair have facilitated improved outcomes and survival rates for blunt TAIs. Compared with blunt TAIs, blunt AAIs are more rare, and open repair is the mainstay of treatment in symptomatic or life-threatening cases.

Conclusions

Much of the data regarding the management of pediatric aortic injuries comes from limited series and case reports. Future research efforts should aim at tracking these repairs, their outcomes, and technical pitfalls to serve as a foundation for future guidelines.
关于儿童主动脉损伤的处理,目前还没有强有力的循证指南。儿童主动脉损伤的模式已经改变,穿透性主动脉损伤继发于弹道损伤的发生率正在增加。治疗模式也发生了变化,随着更多血管内技术的发展,越来越少的主动脉切开修复术能够应用于儿科人群。对于成人人群的可用数据虽然有帮助,但不一定能推断到儿科人群。患者的体型、解剖因素和生长潜力限制了这种方法的适用性。此外,研究对儿科人群的定义不同,儿童、青少年和成年儿科患者的年龄标准差异很大。在创伤人群中,长期随访数据很少甚至不存在。大多数研究是单一机构的评论或病例报告。为了建立治疗儿童主动脉损伤的最佳方法,需要进行更多的研究。这是一篇关于儿童腹主动脉和胸主动脉穿透性和钝性损伤的文献综述。
{"title":"Pediatric aortic trauma: A review of the literature","authors":"Malachi Sheahan MD ,&nbsp;Sarah Lauve MD ,&nbsp;Amanda Tullos MD ,&nbsp;John White MD ,&nbsp;Regan Williams MD ,&nbsp;Dawn Coleman MD ,&nbsp;Claudie M. Sheahan MD","doi":"10.1016/j.jvs.2025.10.036","DOIUrl":"10.1016/j.jvs.2025.10.036","url":null,"abstract":"<div><h3>Background</h3><div>The patterns of pediatric aortic injury have changed and the incidence of penetrating aortic trauma, secondary to ballistic injuries, is increasing. Patterns of treatment have also changed, with fewer open aortic repairs as more endovascular technologies evolve and are able to be applied to the pediatric population.</div></div><div><h3>Methods</h3><div>This is a review of the current available literature regarding pediatric aortic injury both penetrating and blunt in the abdominal and thoracic aorta.</div></div><div><h3>Results</h3><div>When comparing thoracic aortic injuries (TAIs) to abdominal aortic injuries (AAIs), TAI is associated with higher mortality rates. Overall, blunt injuries are more common than penetrating injuries, and there are higher mortality rates associated with penetrating mechanisms. Improvements in endovascular repair have facilitated improved outcomes and survival rates for blunt TAIs. Compared with blunt TAIs, blunt AAIs are more rare, and open repair is the mainstay of treatment in symptomatic or life-threatening cases.</div></div><div><h3>Conclusions</h3><div>Much of the data regarding the management of pediatric aortic injuries comes from limited series and case reports. Future research efforts should aim at tracking these repairs, their outcomes, and technical pitfalls to serve as a foundation for future guidelines.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Pages 914-919"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145426434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
If you're not at the table, you're part of the meal 如果你不在餐桌上,你就是这顿饭的一部分
IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-13 DOI: 10.1016/j.jvs.2025.10.027
Richard J. Powell MD
{"title":"If you're not at the table, you're part of the meal","authors":"Richard J. Powell MD","doi":"10.1016/j.jvs.2025.10.027","DOIUrl":"10.1016/j.jvs.2025.10.027","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"83 3","pages":"Page 952"},"PeriodicalIF":3.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Vascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1